An experimental cancer drug had a 100% success rate : NPR
Jun 7, 2022 · In a very small trial done by doctors at New York's Memorial Sloan Kettering Cancer Center, patients took a drug called dostarlimab for six months. The trial resulted in every single one of...
12 new breakthroughs in the fight against cancer - The World …
Oct 21, 2024 · 1. Personalized cancer vaccines. Thousands of NHS cancer patients in England could soon access trials of a new vaccine treatment. It's designed to prime the immune system to target cancer cells and reduce recurrence risk. These vaccines are also hoped to produce fewer side effects than conventional chemotherapy.
Lifileucel First Cellular Therapy Approved for Cancer
Mar 5, 2024 · In an event more than three decades in the making, the Food and Drug Administration (FDA) has approved lifileucel (Amtagvi), the first treatment for cancer that uses immune cells called tumor-infiltrating lymphocytes, or TILs.
A newly approved ‘living drug’ could save more cancer patients’ …
Aug 22, 2024 · A newly approved ‘living drug’ could save more cancer patients’ lives. Amtagvi, approved for advanced melanoma, is the first T cell therapy for solid tumors. The human immune system produces ...
FDA approves groundbreaking treatment for advanced melanoma - NBC News
Feb 16, 2024 · The Food and Drug Administration on Friday approved a new cancer therapy that could one day transform the way a majority of aggressive and advanced tumors are treated.
Enhertu Approved for Any HER2-Positive Solid Cancer - NCI
May 3, 2024 · The drug trastuzumab deruxtecan (Enhertu) can now be used to treat a wide variety of cancers, thanks to a new approval from the Food and Drug Administration (FDA).
FDA approves inavolisib with palbociclib and fulvestrant for …
Oct 10, 2024 · FDA approves inavolisib with palbociclib and fulvestrant for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer. On October 10, 2024, the Food and Drug ...
First Cancer TCR Cell Therapy Approved by FDA - NCI
Aug 27, 2024 · On August 2, the Food and Drug Administration (FDA) approved a cellular therapy called afamitresgene autoleucel, or afami-cel (Tecelra), to treat some people with metastatic synovial sarcoma, a type of soft tissue sarcoma.
These New Cancer Drugs Improve Outcomes for People with …
Mar 1, 2024 · New drugs called antibody-drug conjugates help patients with cancers that used to be beyond treatment
Can a New Drug Candidate Cure Pancreatic Cancer?
Mar 5, 2024 · The new drug candidate permanently modifies a wily cancer-causing mutation, called K-Ras G12D, that is responsible for nearly half of all pancreatic cancer cases and appears in some forms of lung, breast and colon cancer.